Novo Nordisk's Wegovy Pill: Is Wall Street Missing Something Behind 3 Million Prescriptions?
A new milestone for obesity treatment arrives as Novo Nordisk's Wegovy Pill hits 3 million prescriptions. This articl...
Various factors move the S&P 500, including earnings, macro data, rate expectations, and sector rotations. This intro covers the main influences on index direction.
17,835 articlesA new milestone for obesity treatment arrives as Novo Nordisk's Wegovy Pill hits 3 million prescriptions. This articl...
MIT economist and public thinker Daron Acemoglu argues AI's productivity gains will be modest in the near term, while...
Manchester’s mayor is emerging as Labour’s strongest northern voice in a high-stakes leadership contest. This report ...
Tokyo police have detained a senior figure tied to the Prince Group in a luxury Osaka hotel raid, tying him to a spra...
A federal appeals court blocked the CFPB’s plan to lay off most of its staff, sending the dispute back to a district ...
When markets swing, income-focused stocks can provide ballast. This article explores a dividend growth stock designed...
Regulators move away from wallet limits and toward a per product ceiling for sterling tokens, setting the stage for a...
Rhode Island housing reform advocates take stock after a truncated 2026 session ended without top-priority reform, se...
As AI reshapes computing, three chip giants still worth buying offer a compelling setup for long-term investors. Expl...
In 2026, investors face a clash between disruption and durability: Archer Aviation as a high-growth upstart and Boein...
SpaceX has fallen roughly a third from its peak, sparking questions about its trajectory. This article outlines four ...
A growing cohort of retirees with nest eggs between $800k and $2M can meaningfully reduce lifetime tax bills through ...